CIPO Patents = 7

EPO Patents = 3

Trademarks = 1

Forward Citations = 44

Loading Chart...

6 inventors (with patents filed for the assignee):

Willem Meindert De Vos (5 out of 19 patents)

Max Nieuwdorp (2 out of 5 patents)

Jozef Franciscus Maria Louis Seegers (1 out of 1 patent)

4. Lucas Gerardus Willibrordus Sterkman (1 out of 1 patent)

5. Willem Meindert De Vos (0 patent)

6. Willem Meindert De Vos (0 patent)

5 patents: Sort by Forward Citations

1. 12653848 - FECAL MATTER FOR PREVENTING OR TREATING INTESTINAL MICROBIOME ABERRATIONS IN CESAREAN SECTION-BORN INFANTS (2026-06-16),

2. 10857189 - Compositions and methods for preventing and/or treating vitamin B12 deficiency (2020-12-08),

3. 10806758 - Methods for culturing and preservingand treating disease and preparation thereof (2020-10-20),

4. 9623055 - Method for preventing and/or treating insulin resistance (2017-04-18),

5. 9433650 - Method for preventing and/or treating insulin resistance (2016-09-06),

Company Overview

Caelus Pharmaceuticals B.v. is a leading pharmaceutical company that specializes in the research, development, and commercialization of innovative therapies for various medical conditions. With a focus on improving patient outcomes and quality of life, Caelus Pharmaceuticals B.v. is committed to providing high-quality, effective, and safe treatment options for patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#1 in Zegveld

#1,131 in Netherlands

Zegveld, Netherlands

Caelus Pharmaceuticals B.v.

Forward Citations = 44

6 inventors:

Willem Meindert De Vos (5 out of 19 patents)

Max Nieuwdorp (2 out of 5 patents)

Jozef Franciscus Maria Louis Seegers (1 out of 1 patent)

4. Lucas Gerardus Willibrordus Sterkman (1 out of 1 patent)

5. Willem Meindert De Vos (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Caelus Pharmaceuticals B.v.. Retrieved from https://idiyas.com/company/caelus-pharmaceuticals-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]